Home › Encyclopedia › Hexapeptide-11: Research Status, Identity, and Trial Data
Research / Unapproved

Hexapeptide-11: Research Status, Identity, and Trial Data

Molecular formulaC36H48N6O7
Molecular weight676.8 g/mol
Registered trials0
PubChem CID24998056

What Hexapeptide-11 Is

Hexapeptide-11 is a synthetic peptide compound with the molecular formula C36H48N6O7 and a molecular weight of approximately 676.8 g/mol. It is classified in chemical databases under PubChem CID 24998056. There is no FDA-approved drug label for this compound, meaning no indication, dosing, or safety profile has been officially established by regulators. It is currently studied only as a research compound, not as an approved therapeutic.

Regulatory Status

Hexapeptide-11 is unapproved and is used strictly in a research context. No brand names, approved indications, or labeled mechanism of action exist for this compound at this time.

Trial Footprint

Available registries show no registered clinical trials for hexapeptide-11. This absence of trial data means there is no clinical evidence base currently documented for this compound in human studies.

FAQ

Is hexapeptide-11 FDA approved?
No. Hexapeptide-11 has no FDA-approved label, indication, or brand name. It is classified as an unapproved research compound.
What is the chemical structure of hexapeptide-11?
Hexapeptide-11 has the molecular formula C36H48N6O7 and a molecular weight of about 676.8 g/mol. It is cataloged in PubChem under CID 24998056.
Are there clinical trials studying hexapeptide-11?
Based on available registry data, there are no registered clinical trials for hexapeptide-11. This means there is currently no clinical trial evidence documenting its effects in humans.
What is hexapeptide-11 used for?
Hexapeptide-11 does not have any FDA-approved use. It exists only as a research-stage compound without an established clinical application.
Is there safety data available for hexapeptide-11?
No labeled safety information, side effect data, or adverse event reports are currently available for hexapeptide-11. This reflects its status as an unapproved compound without a formal clinical safety record.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 24998056 ClinicalTrials.gov registry search

Updated 2026-09-19